Deutsche Bank Ag\ Seelos Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.59 - $1.04 $18,937 - $33,381	-32,098 Reduced 51.24%	30,550 $21,000
Q2 2022 Aug 11, 2022	BUY	$0.51 - $0.93 $4,753 - $8,668	9,321 Added 17.48%	62,648 $43,000
Q1 2022 May 13, 2022	SELL	$0.84 - $1.71 $5,322 - $10,834	-6,336 Reduced 10.62%	53,327 $45,000
Q4 2021 Feb 11, 2022	BUY	$1.59 - $2.38 $5,024 - $7,520	3,160 Added 5.59%	59,663 $97,000
Q3 2021 Nov 04, 2021	SELL	$1.69 - $2.89 $382,244 - $653,660	-226,180 Reduced 80.01%	56,503 $136,000
Q2 2021 Aug 11, 2021	BUY	$2.64 - $6.32 $746,283 - $1.79 Million	282,683 New	282,683 $746,000
Q3 2019 Nov 14, 2019	SELL	$0.92 - $2.15 $92 - $215	-100 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$2.11 - $3.3 $211 - $330	100 New	100 $0

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $32M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.